The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock

Chest

Volumn 142, Issue 3, 2012, Pages 593-605

  Gordon, Anthony C ^a   Wang, Nan ^b   Walley, Keith R ^c   Ashby, Deborah ^b   Russell, James A ^c  

^a Faculty of Medicine   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; INOTROPIC AGENT; LACTIC ACID; MILRINONE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN;

ADULT; ARTICLE; CARDIOPULMONARY FUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PH; PRIORITY JOURNAL; PULMONARY ARTERY CATHETER; SEPTIC SHOCK; SYSTOLIC BLOOD PRESSURE;

EID: 84865838898     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2604     Document Type: Article

References (32)

1. Alberti C, Brun-Buisson C, Goodman SV, et al European Sepsis Group. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med. 2003;168(1):77-84. (Pubitemid 37046636)
2. Dellinger RP, Levy MM, Carlet JM, et al International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med.2008;36(1):296-327.
3. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95(5):1122-1125. (Pubitemid 27097820)
4. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997;25(8):1279-1282. (Pubitemid 27347289)
5. Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47(4):699-703.
6. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96(3):576-582. (Pubitemid 34193495)
7. Dünser MW, Mayr AJ, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107(18):2313-2319. (Pubitemid 36578501)
8. Lauzier F, Lévy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med. 2006;32(11):1782-1789. (Pubitemid 44607366)
9. Morelli A, Ertmer C, Rehberg S, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care. 2009;13(4):R130.
10. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med.2001;27(8):1416-1421. (Pubitemid 32758942)
11. Torgersen C, Dünser MW, Schmittinger CA, et al. Current approach to the haemodynamic management of septic shock patients in European intensive care units: a cross-sectional, self-reported questionnaire-based survey. Eur J Anaesthesiol.2011;28(4):284-290.
12. Krejci V, Hiltebrand LB, Sigurdsson GH. Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med. 2006;34(5):1456-1463.
13. Hayes MA, Yau EH, Hinds CJ, Watson JD. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med. 1992;18(7):433-436. (Pubitemid 23009493)
14. Russell JA, Walley KR, Singer J, et al VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877-887. (Pubitemid 351397087)
15. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992;101(6):1481-1483.
16. Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988;94(6):1176-1186. (Pubitemid 19002776)
17. Abraham E, Bland RD, Cobo JC, Shoemaker WC. Sequential cardiorespiratory patterns associated with outcome in septic shock. Chest. 1984;85(1):75-80. (Pubitemid 14215305)
18. Rivers E, Nguyen B, Havstad S, et al Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-1377.
19. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330(24):1717-1722. (Pubitemid 24171030)
20. Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med. 1987;15(10):923-929. (Pubitemid 18055700)
21. Dünser MW, Ruokonen E, Pettilä V, et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13(6):R181.
22. Roy WL, Edelist G, Gilbert B. Myocardial ischemia during non-cardiac surgical procedures in patients with coronary-artery disease. Anesthesiology. 1979;51(5):393-397. (Pubitemid 10198566)
23. Robinson BF. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation. 1967;35(6):1073-1083.
24. Mehta S, Granton J, Cook D, et al. Troponin and CKMB trends in patients with septic shock randomized to vasopressin (VP) or Norepinephrine (NE). Am J Respir Crit Care Med. 2009;179(Abstracts):A1564.
25. Gordon AC, Mehta S, Lapinsky S, et al. Comparison of vasopressin- versus norepinephrine-associated ischemic ECG changes in septic shock. Intensive Care Med. 2009;35(S1):S114.
26. Brame AL, Singer M. Stressing the obvious? An allostatic look at critical illness. Crit Care Med. 2010;38(suppl 10):S600-S607.
27. Rudiger A. Beta-block the septic heart. Crit Care Med.2010;38(suppl 10):S608-S612.
28. National Institutes of Health Clinical Center. Heart rate control with esmolol in septic shock. NCT01231698. Clinical Trials.gov. Bethesda, MD: National Institutes of Health. http://clinicaltrials.gov/ct2/show/NCT01231698. Accessed January 30, 2012.
29. Rehberg S, Ertmer C, Vincent JL, et al. Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med.2011;39(1):119-125.
30. Takala J. Should we target blood pressure in sepsis? Crit Care Med. 2010;38(suppl 10):S613-S619.
31. Morelli A, Donati A, Ertmer C, et al. Effects of vaso-pressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock. Crit Care.2011;15(5):R217.
32. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest.2001;120(3):989-1002. (Pubitemid 32885477)